世界の小分子標的治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Small Molecule Targeted Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4876
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、小分子標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TKI、マルチターゲット阻害剤、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・小分子標的治療の市場動向
・企業の競争状況、市場シェア
・小分子標的治療の種類別市場規模と予測2016-2027（TKI、マルチターゲット阻害剤、その他）
・小分子標的治療の用途別市場規模と予測2016-2027（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）
・小分子標的治療の北米市場規模2016-2027（アメリカ、カナダ）
・小分子標的治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・小分子標的治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・小分子標的治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・小分子標的治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Astrazeneca、Novartis、Millennium Pharmaceuticals、Bayer、Exelixis、Abbvie、Boehringer-Ingelheim、Eisai、Pfizer、Bristol-Myers Squibb、Roche、Bettapharma）
・結論

Market Analysis and Insights: Global Small Molecule Targeted Therapy Market
The global Small Molecule Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Small Molecule Targeted Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Small Molecule Targeted Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Small Molecule Targeted Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Small Molecule Targeted Therapy market.

Global Small Molecule Targeted Therapy Scope and Market Size
Small Molecule Targeted Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Targeted Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
TKI
Multitarget Inhibitor
Others

Segment by Application
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 TKI
1.2.3 Multitarget Inhibitor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Small Molecule Targeted Therapy Market Perspective (2016-2027)
2.2 Small Molecule Targeted Therapy Growth Trends by Regions
2.2.1 Small Molecule Targeted Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Small Molecule Targeted Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Small Molecule Targeted Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Small Molecule Targeted Therapy Industry Dynamic
2.3.1 Small Molecule Targeted Therapy Market Trends
2.3.2 Small Molecule Targeted Therapy Market Drivers
2.3.3 Small Molecule Targeted Therapy Market Challenges
2.3.4 Small Molecule Targeted Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Therapy Players by Revenue (2016-2021)
3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Small Molecule Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Therapy Revenue
3.4 Global Small Molecule Targeted Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Therapy Revenue in 2020
3.5 Small Molecule Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Small Molecule Targeted Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Therapy Historic Market Size by Type (2016-2021)
4.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2022-2027)

5 Small Molecule Targeted Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Therapy Historic Market Size by Application (2016-2021)
5.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Small Molecule Targeted Therapy Market Size (2016-2027)
6.2 North America Small Molecule Targeted Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Therapy Market Size by Type (2016-2021)
6.2.2 North America Small Molecule Targeted Therapy Market Size by Type (2022-2027)
6.2.3 North America Small Molecule Targeted Therapy Market Size by Type (2016-2027)
6.3 North America Small Molecule Targeted Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Therapy Market Size by Application (2016-2021)
6.3.2 North America Small Molecule Targeted Therapy Market Size by Application (2022-2027)
6.3.3 North America Small Molecule Targeted Therapy Market Size by Application (2016-2027)
6.4 North America Small Molecule Targeted Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Therapy Market Size by Country (2016-2021)
6.4.2 North America Small Molecule Targeted Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Small Molecule Targeted Therapy Market Size (2016-2027)
7.2 Europe Small Molecule Targeted Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Therapy Market Size by Type (2016-2021)
7.2.2 Europe Small Molecule Targeted Therapy Market Size by Type (2022-2027)
7.2.3 Europe Small Molecule Targeted Therapy Market Size by Type (2016-2027)
7.3 Europe Small Molecule Targeted Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Therapy Market Size by Application (2016-2021)
7.3.2 Europe Small Molecule Targeted Therapy Market Size by Application (2022-2027)
7.3.3 Europe Small Molecule Targeted Therapy Market Size by Application (2016-2027)
7.4 Europe Small Molecule Targeted Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Therapy Market Size by Country (2016-2021)
7.4.2 Europe Small Molecule Targeted Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Therapy Market Size (2016-2027)
8.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type
8.2.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application
8.3.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region
8.4.1 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Small Molecule Targeted Therapy Market Size (2016-2027)
9.2 Latin America Small Molecule Targeted Therapy Market Size by Type
9.2.1 Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Small Molecule Targeted Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2027)
9.3 Latin America Small Molecule Targeted Therapy Market Size by Application
9.3.1 Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Small Molecule Targeted Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2027)
9.4 Latin America Small Molecule Targeted Therapy Market Size by Country
9.4.1 Latin America Small Molecule Targeted Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Small Molecule Targeted Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Therapy Market Size (2016-2027)
10.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type
10.2.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application
10.3.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country
10.4.1 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Small Molecule Targeted Therapy Introduction
11.1.4 Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.1.5 Astrazeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Small Molecule Targeted Therapy Introduction
11.2.4 Novartis Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Details
11.3.2 Millennium Pharmaceuticals Business Overview
11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Introduction
11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.3.5 Millennium Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Small Molecule Targeted Therapy Introduction
11.4.4 Bayer Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Exelixis
11.5.1 Exelixis Company Details
11.5.2 Exelixis Business Overview
11.5.3 Exelixis Small Molecule Targeted Therapy Introduction
11.5.4 Exelixis Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.5.5 Exelixis Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Small Molecule Targeted Therapy Introduction
11.6.4 Abbvie Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.6.5 Abbvie Recent Development
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Details
11.7.2 Boehringer-Ingelheim Business Overview
11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Introduction
11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.7.5 Boehringer-Ingelheim Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Small Molecule Targeted Therapy Introduction
11.8.4 Eisai Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Molecule Targeted Therapy Introduction
11.9.4 Pfizer Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Introduction
11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Small Molecule Targeted Therapy Introduction
11.11.4 Roche Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Bettapharma
11.12.1 Bettapharma Company Details
11.12.2 Bettapharma Business Overview
11.12.3 Bettapharma Small Molecule Targeted Therapy Introduction
11.12.4 Bettapharma Revenue in Small Molecule Targeted Therapy Business (2016-2021)
11.12.5 Bettapharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Small Molecule Targeted Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of TKI
Table 3. Key Players of Multitarget Inhibitor
Table 4. Key Players of Others
Table 5. Global Small Molecule Targeted Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Small Molecule Targeted Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Small Molecule Targeted Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Small Molecule Targeted Therapy Market Share by Regions (2016-2021)
Table 9. Global Small Molecule Targeted Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Small Molecule Targeted Therapy Market Share by Regions (2022-2027)
Table 11. Small Molecule Targeted Therapy Market Trends
Table 12. Small Molecule Targeted Therapy Market Drivers
Table 13. Small Molecule Targeted Therapy Market Challenges
Table 14. Small Molecule Targeted Therapy Market Restraints
Table 15. Global Small Molecule Targeted Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Small Molecule Targeted Therapy Market Share by Players (2016-2021)
Table 17. Global Top Small Molecule Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Therapy as of 2020)
Table 18. Ranking of Global Top Small Molecule Targeted Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Targeted Therapy Product Solution and Service
Table 22. Date of Enter into Small Molecule Targeted Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Small Molecule Targeted Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Small Molecule Targeted Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Small Molecule Targeted Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Small Molecule Targeted Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Small Molecule Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Small Molecule Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Small Molecule Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Astrazeneca Company Details
Table 63. Astrazeneca Business Overview
Table 64. Astrazeneca Small Molecule Targeted Therapy Product
Table 65. Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 66. Astrazeneca Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Small Molecule Targeted Therapy Product
Table 70. Novartis Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Millennium Pharmaceuticals Company Details
Table 73. Millennium Pharmaceuticals Business Overview
Table 74. Millennium Pharmaceuticals Small Molecule Targeted Therapy Product
Table 75. Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 76. Millennium Pharmaceuticals Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Small Molecule Targeted Therapy Product
Table 80. Bayer Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Exelixis Company Details
Table 83. Exelixis Business Overview
Table 84. Exelixis Small Molecule Targeted Therapy Product
Table 85. Exelixis Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 86. Exelixis Recent Development
Table 87. Abbvie Company Details
Table 88. Abbvie Business Overview
Table 89. Abbvie Small Molecule Targeted Therapy Product
Table 90. Abbvie Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 91. Abbvie Recent Development
Table 92. Boehringer-Ingelheim Company Details
Table 93. Boehringer-Ingelheim Business Overview
Table 94. Boehringer-Ingelheim Small Molecule Targeted Therapy Product
Table 95. Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 96. Boehringer-Ingelheim Recent Development
Table 97. Eisai Company Details
Table 98. Eisai Business Overview
Table 99. Eisai Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 100. Eisai Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Small Molecule Targeted Therapy Product
Table 104. Pfizer Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Small Molecule Targeted Therapy Product
Table 109. Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Roche Company Details
Table 112. Roche Business Overview
Table 113. Roche Small Molecule Targeted Therapy Product
Table 114. Roche Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 115. Roche Recent Development
Table 116. Bettapharma Company Details
Table 117. Bettapharma Business Overview
Table 118. Bettapharma Small Molecule Targeted Therapy Product
Table 119. Bettapharma Revenue in Small Molecule Targeted Therapy Business (2016-2021) & (US$ Million)
Table 120. Bettapharma Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Therapy Market Share by Type: 2020 VS 2027
Figure 2. TKI Features
Figure 3. Multitarget Inhibitor Features
Figure 4. Others Features
Figure 5. Global Small Molecule Targeted Therapy Market Share by Application: 2020 VS 2027
Figure 6. Liver Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Lung Cancer Case Studies
Figure 9. Gastric Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Small Molecule Targeted Therapy Report Years Considered
Figure 14. Global Small Molecule Targeted Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Small Molecule Targeted Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Small Molecule Targeted Therapy Market Share by Regions: 2020 VS 2027
Figure 17. Global Small Molecule Targeted Therapy Market Share by Regions (2022-2027)
Figure 18. Global Small Molecule Targeted Therapy Market Share by Players in 2020
Figure 19. Global Top Small Molecule Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Targeted Therapy as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Targeted Therapy Revenue in 2020
Figure 21. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2016-2021)
Figure 22. Global Small Molecule Targeted Therapy Revenue Market Share by Type (2022-2027)
Figure 23. North America Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Small Molecule Targeted Therapy Market Share by Type (2016-2027)
Figure 25. North America Small Molecule Targeted Therapy Market Share by Application (2016-2027)
Figure 26. North America Small Molecule Targeted Therapy Market Share by Country (2016-2027)
Figure 27. United States Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Small Molecule Targeted Therapy Market Share by Type (2016-2027)
Figure 31. Europe Small Molecule Targeted Therapy Market Share by Application (2016-2027)
Figure 32. Europe Small Molecule Targeted Therapy Market Share by Country (2016-2027)
Figure 33. Germany Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Small Molecule Targeted Therapy Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Small Molecule Targeted Therapy Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Small Molecule Targeted Therapy Market Share by Region (2016-2027)
Figure 43. China Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Small Molecule Targeted Therapy Market Share by Type (2016-2027)
Figure 51. Latin America Small Molecule Targeted Therapy Market Share by Application (2016-2027)
Figure 52. Latin America Small Molecule Targeted Therapy Market Share by Country (2016-2027)
Figure 53. Mexico Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Small Molecule Targeted Therapy Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Small Molecule Targeted Therapy Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Small Molecule Targeted Therapy Market Share by Country (2016-2027)
Figure 59. Turkey Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Small Molecule Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Astrazeneca Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 64. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 66. Exelixis Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 67. Abbvie Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 68. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 69. Eisai Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 72. Roche Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 73. Bettapharma Revenue Growth Rate in Small Molecule Targeted Therapy Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targeted Anti-cancer Drug Market Size, Status and Forecast 2021-2027
QFJ1-6013 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、小分子標的抗がん剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EGFR、ALK、Bcr-Abl、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4374 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の腫瘍小分子薬市場規模・現状・予測（2021年-2027年）

Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4607 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、腫瘍小分子薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学治療薬、免疫調節薬、標的治療薬、ホルモン療法、その他）、用途別市場規模（血液がん、乳がん、消化器がん、前立腺がん、肺がん、その他）、主要...

世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年）

Global Small Molecule Drug Delivery Market Size, Status and Forecast 2021-2027
QFJ1-4875 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、小分子ドラッグデリバリーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（即効性錠剤、カプセル）、用途別市場規模（腫瘍、中枢神経系、心臓血管、呼吸器、整形外科、免疫、希少疾患、その他）、主要地域別市場規...

世界の小分子標的薬市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targted Drug Market Size, Status and Forecast 2021-2027
QFJ1-6014 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、小分子標的薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TKI、マルチターゲット阻害剤、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市場...

世界のRNA標的小分子市場規模・現状・予測（2021年-2027年）

Global RNA-Targeted Small Molecules Market Size, Status and Forecast 2021-2027
QFJ1-5997 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、RNA標的小分子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（mRNA翻訳調節、RNAスプライシング修飾、直接RNAターゲティング、間接RNAターゲティング-エピトランスクリプトミクス）、用途別市場...

世界の小分子抗腫瘍標的薬市場規模・現状・予測（2021年-2027年）

Global Small Molecule Anti-tumor Targted Drug Market Size, Status and Forecast 2021-2027
QFJ1-6012 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、小分子抗腫瘍標的薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EGFR、ALK、Bcr-Abl、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地...

世界の高分子生物分析市場規模・現状・予測（2021年-2027年）

Global Large Molecule Bioanalytical Market Size, Status and Forecast 2021-2027
QFJ1-4410 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、高分子生物分析の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ADME、PK、PD）、用途別市場規模（腫瘍、感染症、心臓病、神経、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界のネオアンチゲン標的療法市場規模・現状・予測（2021年-2027年）

Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5264 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界の肺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Therapy Market The global Lung Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界の小分子標的薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targted Drug Market The global Small Molecule Targted Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…